Date Title 3/16/23 Corporate Presentation – March 2023 2/13/23 OTX-TKI U.S. Phase 1 wet AMD Trial: 10-month Interim Analysis Study Results 9/29/22 Eyecelerator 2022: Ocular Therapeutix - Retina Showcase Presentation
